Accuracy and effectiveness of HPV mRNA testing in cervical cancer screening: a systematic review and meta-analysis

Arbyn M., Simon M., de Sanjose S., Clarke M. A., Poljak M., Rezhake R., ...Daha Fazla

LANCET ONCOLOGY, cilt.23, sa.7, ss.950-960, 2022 (SCI-Expanded) identifier identifier identifier identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 23 Sayı: 7
  • Basım Tarihi: 2022
  • Doi Numarası: 10.1016/s1470-2045(22)00294-7
  • Dergi Adı: LANCET ONCOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CAB Abstracts, CINAHL, EMBASE, MEDLINE
  • Sayfa Sayıları: ss.950-960
  • Hacettepe Üniversitesi Adresli: Evet

Özet

Background Cervical cancer screening tests that identify DNA of the main causal agent, high-risk human papillomavirus (HPV) types, are more protective than cervical cytology. We systematically reviewed the literature to assess whether tests targeting high-risk HPV (hrHPV) mRNA are as accurate and effective as HPV DNA-based screening tests.